Atos and Huma support Symbiosis Hospital to expand care capacity

Atos and Huma, the digital health innovator, are giving their technologies and services to the Symbiosis University Hospital and Research Centre (SUHRC)

Healthcare

Atos and Huma support Symbiosis Hospital to expand care capacity

Atos and Huma, the digital health innovator, are giving their technologies and services to the Symbiosis University Hospital and Research Centre (SUHRC)

Healthcare

Atos and Huma support Symbiosis Hospital to expand care capacity

Healthcare
Healthcare
Healthcare
Healthcare
Headshot of Ed Sykes
Ed Sykes
Head of PR & Communications

Atos and Huma support Symbiosis Hospital to expand care capacity

Healthcare
Healthcare
Healthcare
Headshot of Ed Sykes
Ed Sykes
Head of PR & Communications

Hospital at home

Atos and Huma, the digital health innovator, are giving their technologies and services to the Symbiosis University Hospital and Research Centre (SUHRC), constituent of Symbiosis International University (SIU), in Pune, India. SUHRC patients are now starting to receive the latest medical care with a new remote patient monitoring system which uses smartphone technology, a pulse oximeter and includes a portal for clinicians. This ‘hospital at home’ will allow the SUHRC to expand its capacity by around 40-60%.

The ‘hospital at home’ system, delivered by Atos and built by Huma, is based on Huma’s award-winning remote patient monitoring system that has already been used across England and Germany. The system effortlessly helps monitor blood oxygen levels, heart rate and symptoms through a smartphone, flagging potentially deteriorating and high-risk patients. Clinicians can manage multiple patients, and with the available inputs can conduct consultations and care for their patients remotely. The technology can help remotely manage patients diagnosed with COVID-19 and also post-COVID discharged patients. Additionally, the system reassures patients that help is always available, that they are being cared for and notifies them when a clinician has assessed their data. It will also help drive research into the impact of the virus.

“This symbiotic industry-academia partnership will help us deploy technology to provide healthcare services to patients in and around Pune. This will be in line with the National agenda as envisioned in the National Digital Health Mission (NDHM) for India.” said Dr Rajiv Yeravdekar, Dean, Faculty of Health Sciences, SIU. “India had a large COVID-19 caseload but has a limited awareness on post-COVID care monitoring. We still need to learn more about this disease and its long and devastating impact on people. Monitoring a large volume of patients will help us identify those in need of immediate care.”

Key features of the ‘hospital at home’ include an around-the-clock medical command center staffed by SUHRC clinicians and an integrated care team at SUHRC that delivers in-person care to patients who need to be admitted. Hospital staff will speak with the patients remotely and adjust care plans if necessary via telemedicine. This will not only avoid unnecessary travel and exposure but also help the SUHRC manage bed capacity.

Robert Vassoyan, Head of Healthcare and Lifescience, Atos, said: “Digital technology has proven to be a vital resource in the fight against COVID-19 and as a digital leader, we are proud to be able to help patients and frontline workers together with our partner Huma. Our project with the Symbiosis University Hospital and Research Centre (SUHRC) in Pune is replicable throughout India and we are open to bring this technology and services to other hospitals if needed.”

Dan Vahdat, CEO and Founder of Huma, said: “We want to make a difference for the people of Pune, with our fast-to-deploy technology, combined with Atos’ proven ability to deliver complex projects and SUHRC’s expertise in providing healthcare to citizens in and around Pune. Evidence shows our digital approach can double clinical capacity and achieve high levels of engagement and adherence with patients, including older people. This project marks the beginning of a 5-year strategic global partnership between Atos and Huma to shift healthcare and clinical trials from hospitals to homes, across many different chronic and episodic illnesses.”

What’s a Rich Text element?

What’s a Rich Text element?

What’s a Rich Text element?

What’s a Rich Text element?
What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

  • bullet list item
  • bullet list item
  • bullet list item

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

  1. numbered list item
  2. numbered list item
  3. numbered list item
Image caption
Button Text
Author Name
Author Paragraph
Quote Text

Author Name

Quote Text

Author Name

Author Role

Author Name

Author Role

Author Paragraph
Download Title
Download Paragraph
Download Button Text
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Download
Download Whitepaper
Navigating the DCT transition: How to set up a digital-first trial that meets patient and study needs.
Download
No items found.
Table of Contents
Table of Content Link
Table of Content Link
Table of Content Link
Table of Content Link
Table of Content Link
Share this

Request a meeting

This field is required
This field is required
This field is required
This field is required
Country/Region ⃰
This field is required
I'm interested in

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

Submit
Thank you.
We will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

Sources

COMPANY

About Huma

Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents.

Learn more

Contact Us

Related Articles

See More
Article
Huma's innovative approach to tackling medication adherence
Medication non-adherence poses a significant problem that not only impacts the patient but also the healthcare system.
Learn more
SaMD Companion App Pharma
Healthcare
Article
Health for All: Why Planetary Health is Key to Achieving Global Wellness
To mark its 75th anniversary, the World Health Organisation has made Health for All the focus for this year. This Earth Day, we are looking at how planetary health is an essential component of reaching that goal.
Learn more
Healthcare

Related Blogs

See More
Blog
Breathe Easier: The Power of Digital Health in Asthma Care and Research
Asthma is a respiratory condition that affects over 300 million people globally. Without treatment, it can lead to life-threatening attacks. Read more to explore how digital health technologies can help patients manage their symptoms effectively.
Learn more
Blog
Growth for good: how Huma is scaling its business to improve patients’ lives
A strong start to 2023: Huma wins Tech Tour Growth50’s Health Award and is named the Financial Times’ fastest growing healthcare company in Europe 
Learn more

Related White Papers

See More
A female nurse working on an iPad.
White Paper
Navigating the DCT transition
Learn how remote trial technology is changing the clinical trial landscape and key considerations when including DCT components in your study protocols.
Learn more

Related Ebooks

See More
Ebook
Welcome to next-generation digital-first care and research
Deliver more personalised digital-first care and research with the first disease agnostic enterprise platform to achieve EU MDR Class IIb certification1.
Learn more
Ebook
What does FDA 510(k) Class II mean for Huma and our partners
Deliver more personalised digital-first care and research with our enterprise platform which now has FDA 510 (K) Class II clearance for any physician-specified condition.
Learn more